5 Topical Drugs in Development for Atopic Dermatitis
David Rosmarin, MD, reviews a quintet of promising agents advancing in late stages while at RAD 2023.
Source: hcplive.com
Page 15 - Published March News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Published March. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Published March Today - Breaking & Trending Today
Government Contracts Legal Round-Up | 2023 Issue 7 - Government Contracts, Procurement & PPP
Welcome to Jenner & Block's Government Contracts Legal Round‑Up, a biweekly update on important government contracts developments. This update offers brief summaries of key...
Source: mondaq.com
FDA Issues Complete Response Letter for TransCon PTH in Hypoparathyroidism
Announced on May 1, the CRL from the FDA expressed concerns related to manufacturing control strategy, but did not express concern related to clinical data submitted as part of the NDA package for TransCon PTH.
Source: hcplive.com
Analysis Details Effects of Dapagliflozin on Total Events in HFmrEF, HFpEF
A prespecified analysis of the DELIVER trial provides insight into the effects of dapagliflozin use on total heart failure events in patients with mildly reduced or preserved ejection fraction.
Source: hcplive.com
Durvalumab Plus Chemo Is Tolerable in Real-World Representative ES-SCLC Population
First-line durvalumab plus up to 6 cycles of platinum and etoposide is safe and tolerable with signals of clinical efficacy consistent with those previously seen in patients with treatment-naïve extensive-stage small cell lung cancer.
Source: onclive.com